Back to top

Image: Bigstock

Humana (HUM) Down 4.2% Since Last Earnings Report: Can It Rebound?

Read MoreHide Full Article

A month has gone by since the last earnings report for Humana (HUM - Free Report) . Shares have lost about 4.2% in that time frame, outperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Humana due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

How Have Estimates Been Moving Since Then?

It turns out, estimates revision have trended upward during the past month.

The consensus estimate has shifted 41.68% due to these changes.

VGM Scores

Currently, Humana has a poor Growth Score of F, a grade with the same score on the momentum front. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Humana has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry Player

Humana is part of the Zacks Medical - HMOs industry. Over the past month, Cigna (CI - Free Report) , a stock from the same industry, has gained 6.3%. The company reported its results for the quarter ended December 2024 more than a month ago.

Cigna reported revenues of $65.68 billion in the last reported quarter, representing a year-over-year change of +28.4%. EPS of $6.64 for the same period compares with $6.79 a year ago.

For the current quarter, Cigna is expected to post earnings of $6.41 per share, indicating a change of -0.9% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for Cigna. Also, the stock has a VGM Score of C.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Humana Inc. (HUM) - free report >>

Cigna Group (CI) - free report >>

Published in